Following injection of 105 cells of each fraction we found no significant differences in tumor volumes of either CD133− and CD133+, unsorted or CD271+ cells, respectively, suggesting a similar tumorigenic capacity of all cellular fractions (Figure 2D and Table S2). This evidence concerns the gene PROM1 and neoplasm.